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Abstract
Chitosan is a polysaccharide derived from chitin; chitin is the second most abundant pol‐
ysaccharide in the world, after cellulose. Chitosan is biocompatible, biodegradable and
non-toxic, so that it can be usedin medicalapplications such as antimicrobial and wound
healing biomaterials. It also used as chelating agent due to its ability to bind with choles‐
terol, fats, proteins and metal ions.
Chitosan is difficult to electrospun into a fibrous structure because it has a polycationic
character in an acidic aqueous solution due to the many amino groups in its backbone.
Fibrous structures were successfully formed by electrospinning chitosan solutions in 90
wt. % aqueous acetic acid solution or trifluoroacetic acid (TFA) or TFA/dichloromethane
(DCM) in the presence of poly vinyl alcohol (PVA) or Poly ethylene oxide(PEO).Chitosan
nanofibers are biocompatible and biodegradable, so they can used as hemostatic and
wound healing materials.
Keywords: Chitosan, Biocompatibility, Biodegradability, Antimicrobial activity, Func‐
tionality, Nanofibers, Elecrtrospinning
1. Introduction
Chitosan is a polysaccharide derived from chitin; chitin is the second most abundant polysac‐
charide in the world, after cellulose. The presence of amino groups in the chitosan structure
might be protonated-providing solubility in diluted acidic aqueous solutions, several remark‐
able properties of chitosan offered unique opportunities to the development of biomedical
applications. The elucidation of their mechanism will lead to a better understanding of chitosan
medical and pharmaceutical interest. The haemostatic activity of chitosan can also be related
to the presence of positive charges on chitosan backbone. Due to its positive charges, chitosan
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can also interact with the negative part of cells membrane, which can lead to reorganization
and an opening of the tight junction proteins, explaining the permeation enhancing property
of this polysaccharide.
The polycationic nature of chitosan also allows explaining chitosan analgesic effects. Now, to
explain chitosan biodegradability, it is important to remember that chitosan is not only a
polymer bearing amino groups, but also a polysaccharide, which consequently contains
breakable glycosidic bonds. Chitosan is actually degraded in vivo by several proteases, and
mainly lysozyme.
Chitosan is biocompatible, biodegradable and non-toxic, so that it can be used as medical
applications as antimicrobial and wound healing biomaterials. It used as chelating agent due
to its ability to bind with cholesterol, fats, proteins and metal ions [1]
Due to chitosan’s many attractive properties such as biodegradability, natural origin, abun‐
dance, reactivity, etc., it has many areas of application including medical, agricultural, food
processing, nutritional enhancement, cosmetics, and waste and water treatment.
Chitosan is difficult to electrospun into a fibrous structure because it has a polycationic
character in an acidic aqueous solution due to the many amino groups in its backbone. Fibrous
structures were successfully formed by electrospinning chitosan solutions in 90 wt. % aqueous
acetic acid solution or by using trifluoroacetic acid (TFA) or TFA/dichloromethane (DCM).
Since the electrospinning of chitosan itself proved to be difficult, chitosan was mixed with
other synthetic or natural polymers, such as PEO or PVA.
Chitin and chitosan nanofibers with (50-500nm diameter) are biocompatible and biodegrada‐
ble, so they can used as hemostatic and wound healing materials [2].
2. Chitosan
Chitosan is a polysaccharide derived from chitin. Its molecular weight is typically between
300-1000 kDa depending on the source of chitin. After cellulose, chitin is the second abounant
natural polymer in the world. It is found in crustacean such as shrimps and crab [1, 3]
The main Sources of Chitin and Chitosan are : Insects (e.g. Cuticle, Ovipositors and Beetle
cocoon), Crustaceans e.g. (Crab shell and Shrimp shell), Squid e.g. (Ommastrephes pen and
Loligo stomach wall), Centric Diatoms e.g. (Thalassiosira fluviatilis and Algae) and Fungi e.g.
(Mucor rouxi and Aspergillis nidulans).
Chemical structure of chitin made up of 1-4 linked 2-acetamido-2-deoxy-β-D-glucopyranose
(Figure 1).
Although chitin is found naturally in large amounts through many sources, chitosan is only
found in nature in limited quantities, such as in some fungi. The chitosan used in industrial or
research applications is typically derived from chitin through the use of chemical or enzymatic
treatments [4].
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Chitosan is a copolymer of N-acetyl-D-glucose amine and D-glucose amine as shown in figure
2.It is a linear and semicrystals polymer [5, 6] chitosan has de acetylation degree at least 60%
of glucose amine residue.(which corresponds to a deacetylation degree of 60). The deacetyla‐
tion of chitin is conducted by chemical hydrolysis under severe alkaline conditions or by
enzymatic hydrolysis in the presence of particular enzymes, among of chitin deacetylase [7, 8].
After cellulose, chitin is the second most abundant biopolymer [6] and is commonly found in
invertebrates as crustacean shells or insect cuticles but also in some mushrooms envelopes,
green algae cell walls, and yeasts [9-11]. At industrial scale, the two main sources of chitosan
are crustaceans and fungal mycelia; the animal source shows however some drawbacks as
seasonal, of limited supplies and with product variability which can lead to inconsistent
physicochemical characteristics [12]. The mushroom source offers the advantage of a control‐
led production environment all year round that insures a better reproducibility of the resulting
chitosan [13], chitosan is safe for both healthcare and biomedical application [5, 14]. The
mushroom-extracted chitosan typically presents a narrower molecular mass distribution than
the chitosan produced from seafood [14], and may also differ in terms of molecular mass, DD
and distribution of deacetylated groups [13, 15]. Chitosan DD greatly varies between 60 and
100% while its molecular weight typically ranges from 300 to 1000 kDA [16], depending on the
source and preparation. Chitosan oligomers can be prepared by degradation of chitosan using
specific enzyme [5] or reagent as hydrogen peroxide [17].
After production, many different tools such as pH-potentiometric titration, IR-spectroscopy,
viscosimetry, 1H NMR spectroscopy, UV-spectroscopy, and enzymatic degradation can
determine chitosan properties [5, 6, 18].
2.1. The relationship between structure and properties
Chitosan differ from chitin by the presence of amino groups which appears in its solubility in
dilute acids (pH < 6), and forming complexes with metal ions so that it can be used for waste
water treatment and purification. [5, 6]. In contrast, practical applications of chitin are
extremely limited due to its poor solubility, if any [19]. Interestingly, the aqueous solubility of
chitosan is pH dependent allowing processability under mild conditions [20].
Chitosan with protonated amino groups becomes a polycation that can subsequently form
ionic complexes with a wide variety of natural or synthetic anionic species [20],  such as
lipids, proteins, DNA and some negatively charged synthetic polymers as poly (acrylic acid)
[19-22].  As a  matter  of  fact,  chitosan is  the  only  positively  charged,  naturally  occurring
polysaccharide [19].
Figure 1. Chemical structure of chitin [4].
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Chitosan molecules have both amino and hydroxyl groups so that it can form stable covalent
bonds via several reactions such as etherification, esterification and reductive amination
reactions [5, 6].
Chitosan have remarkable antibacterial activity [5, 23, 24], along with antifungal [11], mu‐
coadhesive [25], analgesic [11] and haemostatic properties [26]. It can be biodegraded into non-
toxic residues [27, 28] the rate of its degradation being highly related to the molecular mass of
the polymer and its deacetylation degree – and has proved to some extent biocompatibility
with physiological medium [29, 30]. All these singular features make chitosan an outstanding
candidate for biomedical applications.
Chitosan, deacetylated form of chitin to at least 50% of the free amine form, has a heterogeneous
chemical structure made up of both 1-4 linked 2-acetamido-2-deoxy-β-D-glucopyranose as
well as 2-amino-2-deoxy-β-D-glucopyranose (Figure 2).
Figure 2. Chemical structure chitosan [4].
2.2. Chitin and chitosan production
Chitosan produced from crustacean shell such as crab and shrimp. These shells contains
30-40% proteins, 30-50% calcium carbonate and 20-30% chitin (etd.lsu.edu).
Production of chitosan involves four steps: demineralization, (DM), deproteinization (DP),
decolorization (DC), and deacetylation (DA), as shown in Figure 3 (etd.lsu.edu).
The process for the deacetylation of chitin, obtained from crab or shrimp shells, to form
chitosan is described in Figure 5 and generally produces a chitosan with 70% to 95% deacety‐
lation [4].
3. Chitosan as biomaterial
Chitosan have several properties to be used in biomedical applications. It has positive charges
in acidic medium, due to protonation of amino groups, and it can bind with negative residues
in the mucin, that lead to improve mucoadhesive properties [5, 15].
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Also positive charges on chitosan can bind to negative charges on red blood cells (RBC) so that
chitosan used as haemostatic agent [5, 32, 33].
Chitosan has two mechanisms to explain its antimicrobial activity. The first mechanism
proposed that positive charges on chitosan could bind with negative charges at the bacterial
cell surface, which alter permeability and leaks solutes outside the cells. The second one
proposed that it could bind with bacterial DNA cell, which inhibit RNA synthesis [5].
The polycationic nature of chitosan also allows explaining chitosan analgesic effects. Indeed,
the amino groups of the D-glucosamine residues can protonate in the presence of proton ions
that are released in the inflammatory area, resulting in an analgesic effect [34].
Figure 3. Chitosan production flow scheme [4, 31].
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Now, to explain chitosan biodegradability, it is important to remember that chitosan is not
only a polymer bearing amino groups, but also a polysaccharide, which consequently contains
breakable glycosidic bonds. Chitosan is actually degraded in vivo by several proteases, and
mainly lysozyme [11, 35, 36]. Till now, eight human chitinases have been identified, three of
them possessing enzymatic activity on chitosan [37]. The biodegradation of chitosan leads to
the formation of non-toxic oligosaccharides of variable length. These oligosaccharides can be
incorporated in metabolic pathways or be further excreted [38]. The degradation rate of
chitosan is mainly related to its degree of deacetylation, but also to the distribution of N-acetyl
D-glucosamine residues and the molecular mass of chitosan [39-41].
Chitosan shows biocompatibility in biomedical applications such as sutures and artificial skins
[5, 6, 10, 34] and was notably approved by the Food and Drug Administration (FDA) for use
in wound dressings [42]. However, the compatibility of chitosan with physiological medium
depends on the preparation method (residual proteins could indeed cause allergic reactions)
and on the DD – biocompatibility increases with DD increase. Chitosan actually proved to be
more cytocompatible in vitro than chitin. Indeed, while the number of positive charges
increases the interaction between cells and chitosan increases as well, which tends to improve
biocompatibility [43].
Besides, some chemical modifications of chitosan structure could induce toxicity [35].
Production process of chitosan has great effect on chitosan properties because these processes
control the degree of acetylation of chitosan, i.e. free amino groups that allow it to bind with
negatively charged molecules [1, 4, 44].
Chitosan has several biological properties that make it an attractive material for use in medical
applications. These properties include: biodegradability, lack of toxicity, anti-fungal effects,
wound healing acceleration and immune system stimulation [4, 44-46].
4. Applications of chitosan and chitosan derivatives
Due to chitosan’s many attractive properties such as biodegradability, natural origin, abun‐
dance, reactivity, etc., it has many areas of application including: medical, agricultural, food
processing, nutritional enhancement, cosmetics, and waste and water treatment [4, 44].
4.1. Agricultural applications
The abundance, biodegradability, nontoxic, and natural origin of chitosan allow it to be safely
used in agricultural applications because it can be used without concerns of pollution, disposal,
or harm to consumers if ingested. Seed coating, leaf coating, fertilizer, and time released drug
or fertilizer responses are some of the applications within agricultural where chitosan is
utilized. The use of chitosan in these areas has shown to increase the amount of crops produced
by improving germination, rooting, leaf growth, seed yield, and soil moisture retention, while
reducing the occurrence of fungal infections and diseases [47].
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4.2. Wastewater treatment applications
Chitosan’s functional groups and natural chelating properties make chitosan useful in
wastewater treatment by allowing for the binding and removal of metal ions such as copper,
lead, mercury, and uranium from wastewater [4]. It can also be utilized to breakdown food
particles that contain protein and remove dyes and other negatively charged solids from
wastewater streams and processing outlets [47].
4.3. Food industry applications
Chitosan’s chelating properties and high functionality make it valuable in several applications
within the food industry such as binding with and removing certain elements, particles, and
materials such as dyes and fats from foods. The antibacterial and antifungal properties found
in chitosan can also be used during the storage and preservation of food [4, 46, 47].
4.4. Medical applications
Due to chitosan’s ability to function in many forms it has many areas of interest within the
medical industry including orthopedic and Periodontal Applications [44, 46]. Tissue engi‐
neering [44, 45, 47-49], Wound Healing [44, 45, 50, 51] and Drug Delivery [52, 53].
Some examples of biomedical applications of are artificial skin, surgical sutures, artificial blood
vessels, controlled drug release, contact lens, eye humor fluid, bandages, sponges, burn
dressings, blood cholesterol control, anti-inflammatory, tumor inhibition, anti-viral, dental
plaque inhibition, bone healing treatment, wound healing accelerator, hemostatic agent,
antibacterial agent, antifungal agent, weight loss effect [44].
5. Electrospinning of chitosan
Electrospinning is a process that utilizes a strong electrostatic field to obtain ultrafine fibers
from a polymer solution accelerated towards the grounded collector due to the motion of
charge carriers present in the solution in order to complete the electrical circuit. Electrospun
fibers with their high surface area to volume ratio and small pores, are drawing interest in vast
variety of applications, some being, filtration products, scaffolds for tissue engineering, wound
dressings, drug release materials, fiber reinforcement composites, protective clothing [54-56].
5.1. History of electrospinning
In 1700s, influence of electrostatics was observed on water behavior and an electric charge
influenced the excitation of dielectric liquid. This probably led to the invention of electrospin‐
ning to produce fibers in the early 1900s by Cooley and Morton. Cooley added rotatory
electrode to the electrospinning jet. Formhals, in 1930, produce yarns by using electrospinning
without spinneret [57] and patented his invention relating to the process and the apparatus.
In 1940, Formhals patented another method for producing composite fiber webs from multiple
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polymer substrates by electrostatically spinning polymer fibers on a moving base substrate.
In 1969, Taylor studied the shape of the polymer droplet produced at the tip of the needle when
an electric field was applied and showed that it was a cone and the jets ejected from the vortices
of the cone. This cone was later referred to as the ‘Taylor cone’. The effects of electric field,
experimental conditions and the factors affecting the atomization and fiber stability were
studied [58]. For the fiber industries, one important consideration is the rate of fiber produc‐
tion. Electrospinning, compared to the popular industrial fiber spinning processes, has very
low production rates [57]. Industrial dry spinning has a yarn take-up rate of 200– 1500 m min
−1 while yarn fabricated from electrospinning has a take-up speed of 30 m min−1. Thus, before
1990, there was very little industrially oriented research interest found on electrospinning.
Melt spinning being the preferred method for producing synthetic fibers, efforts were made
to electrospin fibers using polymer melts, but difficulties were encountered in fabricating fibers
with nanometer diameters and, therefore, little progress was made in this specific approach.
Nevertheless, Dalton et al [59] recently succeeded in depositing electrospun polymer melt
fibers directly on to cells to form layered tissue constructs for tissue engineering. This elimi‐
nated the introduction of cytotoxic solvents into the cell culture when the fibers were depos‐
ited. While there have been patents filed for various electrospinning set-ups since the 1900s, it
is only in the last decade that academia got heavily involved in using electrospinning to
fabricate various nano-fibrous assemblies for a range of potential applications.
Figure 4 shows a comparison of diameters between nanofibers, proteins, viruses and bacterial
cells [60].
Figure 4. Comparison of the Diameters of Electrospun Fibers to those of Biological and Technological Objects [60].
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5.2. Electrospinning process
Electrospinning as the production of fine fibers (either nano or micro) from polymer solutions
by using high voltage electric field (kV) at room temperature and atmospheric conditions There
are two electrospinning setups, vertical and horizontal [1, 61, 62].
Electrospinning devices, Figure 5, consists of three main componenet: high voltage electric
field, spinneret and collecting electrode.[1, 63, 64].
Through electrospinning process, polymer solutions subjected to high voltage electric field
that induce electric charge on its surface. At critical electric field, the repulsive electrical forces
can overcome the surface tension and eject unstable charge jet from Taylor cone tip, which
evaporate the solvent and leave the polymer [1, 65-68]. The jet is only stable at the tip of the
spinneret and after that, instability starts. Thus, the electrospinning process offers a simplified
technique for fiber formation.
Due to the critical voltage, applied potential reaches a critical value and the repulsive force
within the charged solution exceeds surface tension and a jet erupts from the tip of the cone.
These charged ions in the polymer jet move in response to the applied electric field towards
the electrode of opposite polarity, thereby transferring tensile forces to the polymer jet making
the latter undergo a chaotic motion or bending instability with whipping action. The jet moves
towards the opposite charged collector, which collects the charged fibers. The jet ejected from
the apex of the cone continues to thin down along the path of its travel towards the collector.
As the jet travels through the atmosphere, the solvent evaporates, leaving behind a dry fiber
on the collecting device. The structure formation happens on a millisecond scale[69]. An
important step within production of the fibers is the elongation taking place within the jet with
a strain rate as high as 104 sec-1[55, 58, 70, 71].
Figure 5. Schematic illustration of electrospinning setup [56].
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A typical electrospinning setup only requires a high voltage power supply, a syringe, a flat tip
needle and a conducting collector as shown in Figure 7. Electrospinning is able to produce
continuous nanofibers from a wide range of materials. Nevertheless, there are many parame‐
ters, which affect the fiber morphology and properties in electrospinning. The main parameters
are polymer parameters and processing conditions [54, 56, 72].
5.3. Effects of various parameters on electrospinning
There are several parameters affect the electrospinning process. These parameters are solution,
process and ambient parameters [1, 56, 73]. In Table 1, there are summary of various parameters
and their effects on fiber morphology[1].
Parameters Effect on fiber morphology
Solution parameters
Viscosity (η) Low (η) generate beads, high (η) causes increase in fibre diameter and
disappearance of beads
concentration Fibre diameter increase with increasing of polymer concentration.
Molecular weight of polymer The number of beads decrease, with increasing of molecular weight.
Conductivity Decrease in fiber diameter with increase in conductivity.
Surface tension Jets. Instability appears with high surface tension
Processing parameters
Applied voltage Decrease in fiber diameter with increase in voltage.
Distance between tip and collector Generation of beads with too small and too large distance, minimum distance
required for uniform fibers.
Feed rate/Flow rate Decrease in fiber diameter with decrease in flow rate, generation of beads with too
high flow rate.
Ambient parameters
Humidity High humidity results in circular pores on the fibers.
Temperature Increase in temperature results in decrease in fiber diameter.
Table 1. Electrospinning Parameters (Solution, Processing and Ambient) and their Effects on Fiber Morphology [1].
5.4. Solvents used for electrospinning
Solvents play an important role in electrospinning to the dissolution of polymer in soluble
solvent is the first step in the electrospinning process. These solvents should be volatile and
have low boiling point such as chloroform, ethanol, dimethylformamide (DMF), trifluoroacetic
acid (TEA), dichloromethane (DCM) [1, 74-76].
Solution properties such as viscosity and surface tension have great effect on the morphology
of nanofibers [1, 77].
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Basically, a solvent performs two crucial roles in electrospinning: Firstly, to dissolve the
polymer molecules for forming the electrified jet. Secondly to carry the dissolved polymer
molecules towards the collector [78], e.g. dimethylformamide, a dipolar aprotic solvent, has
been successfully used as a solvent for electrospinning of poly (acrylonitrile) and its addition
enhances the solution conductivity which is a prerequisite for the formation of bead free
uniform fibers [79]. It was found that by increasing the concentration, there was a gradual
decrease in surface tension of the solution, which favoured production of thinner fibers [80].
6. Electrospinning of chitosan solutions
Chitosan cannot form nanofibers through electrospinning process because its poly cationic
nature due to the presence of many amino groups in its structure which increase solution
surface tension [2, 81].
Fibrous structures were successfully formed by electrospinning chitosan solutions in 90wt%
aqueous acetic acid solution [80] or by using trifluoroacetic acid (TFA) or TFA/dichlorome‐
thane (DCM) [78]. However, electrospinning conditions are relatively limited in terms of
concentration, molecular weight, and degree of deacetylation [82]. The resultant chitosan fibers
need to be cross-linked to maintain their structural integrity, as they can readily swell in
aqueous solution [83].
Since the electrospinning of chitosan itself proved to be difficult. Chitosan was mixed with
other synthetic or natural polymers, such as PEO in aqueous acid, PVA, aqueous acetic acid
solution or aqueous acrylic acid solution, poly (lactic acid) (PLA) in trifluoroacetic acid/
methylene chloride mixture solvents or its copolymers in aqueous acetic acid solution, silk
fibroin (SF) in formic acid, and collagen in 1,1,1,3,3,3,-hexafluoro-2-propanol/trifluoroacetic
acid mixture solvent [2]. Several chitosan derivatives such as hexanoyl chitosan in Chloroform
as a solvent, quaternized chitosan aqueous acetic acid solution or Water, N-carboxyethylchi‐
tosan in aqueous acrylic acid solution or water as solvent, and chitosan grafts with L-lactide
or PEG oligomer in dimethylformamide/tetrahydrofuran solvent [2] were synthesized and
electrospun with or without polymer additives, to improve the solubility and electrospinna‐
bility of chitosan
Chitin and chitosan nanofibers are biocompatible, biodegradable and nono-toxic so that it is
used in biomedical applications such as antithrombogenic, hemostatic, and wound healing.
The use of nanofibrous chitosan matrices is thus expected to mimic the natural ECM, in which
cells attach, proliferate, and differentiate [2, 84, 85]. The use of nanofibrous chitosan matrices
is thus expected to mimic the natural ECM, in which cells attach, proliferate, and differentiate.
An organic/inorganic composite scaffold of hydroxyapatite (HAp) and electrospun nanofi‐
brous matrix was prepared by using chitosan/poly(vinyl alcohol) (CS/PVA) and N-carboxye‐
thylchitosan/PVA (CECS/PVA) electrospun membranes, and HAp was formed in
supersaturated CaCl2 and KH2PO4 solution [86].
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Xu et al was successful to prepare chitosan nanofibers used for enzyme immobilization by
mixing its solution with polyvinyl alcohol (PVA) then added to sodium hydroxide solution
for remaining the PVA and stabilizing chitosan nanofibers [87].
Chitosan nanofibers used for wound healing because it shows antibacterial activity against
Staphylococcus aureus and Escherichia coli [87, 88]. In addition, chitosan nanofibers with
(40-290 nm diameters) were prepared by electrospinning of its solution with polyethylene
oxide (PEO) blended solution [89].
Quaternized chitosan (QCS) form nanofibers in the presence of polyvinyl alcohol (PVA) and
poly vinyl pyrrolidone (PVP) as fiber aiding materials [90, 91].
Ultrafine fibers could be generated by controlling the addition of PEO in 2:1 or 1:1 mass ratios
of CS to PEO from 4–6 wt% CS/PEO solutions to be used for cartilage tissue repair [92, 93].
Chitosan electrospun nanofibers are cellular biocompatible. Chitosan molecular and solvent
used control the beads formation such as hexanoyl chitosan/poly lactide nanofibers in
chloroform formed without beads. Also in chitosan/PVA nanofibers, beads formation de‐
creased by increased the content of PVA repair [92, 94].
PVA are non-toxic, non-ionogenic and water-soluble polymer. Therefore, the nanofibrous
materials prepared by electrospinning of CECS/PVA aqueous solutions, dissolved when put
in contact with water. CECS / PVA mats stabilized by heating at 100oC. it is used in tissue
schafolds applications [92, 94]. FTIR, XRD, and DSC studies demonstrated that there were
strong intermolecular hydrogen bonds between the molecules of CS and PVA in the PVA/CS
blend nanofibrous membranes [95]. SEM images showed that the morphology and diameter
of the nanofibers were mainly affected by concentration of the blend solution (weight ratio of
the blend) respectively [95]. It appears that electrospinning may emerge as a versatile method
to manufacture CS fibers.
7. Nanofibers produced by electrospinning
7.1. Nanofiber morphology
Nanofibers produced by electrospinning have gained popularity in research in part due to
their morphological characteristics. These nano-diameter fibers have high surface areas, small
pore sizes and are able to be produced in three dimensional forms (Figure 6). Because the above
mentioned characteristics can be modified through process parameters to suit individual
applications and needs, electrospinning has become a growing topic among researchers [71].
7.2. Nanofiber properties
The properties associated with nanofibers can be traced back to both process parameters and
morphological characteristics. For example electrospun fibers have small pores that are a result
of the evaporation of the solvent used during the electrospinning process and these pores affect
mechanical properties of the fibers such as tensile strength and Young’s modulus [58]. Other
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studies have found that the physical properties of nanofibers tend to be somewhat inferior to
that of their film and resin counterparts of a similar thickness. [65, 71] This is believed to be a
result of lower crystallinity due to rapid evaporation of the solvent followed by rapid cooling,
which occurs in the final stages of the electrospinning process [58].
7.3. Nanofiber applications
Characteristics such as large surface areas and the ability to be engineered in various forms
have allowed nanofibers to be used in applications including: filtration [51], composite
reinforcement [96], multifunctional membranes [51], tissue engineering scaffolds [3, 45, 51, 97,
98], wound dressings [50, 65, 99, 100], drug delivery [100-102], artificial organs [65, 103], and
vascular grafts [65, 102-104]. Although all of these areas of interest are, still studied, biomedical
applications for polymeric nanofibers have made up a majority of the new growth in the field
of nanofiber research (Figure 7). [65] This growth is in part due to increased understanding of
the human body, cellular structure, and the body’s reaction to foreign materials.
Figure 7. An estimation of the targeted nanofiber research fields based on the number of patent applications for elec‐
trospun nanofibers [65].
Figure 6. Scanning electron microscopy (SEM) image of electrospun poly (vinyl alcohol) produced on laboratory elec‐
trospinning setup.
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Researchers in the past have made attempts to electrospin chitosan in order to further utilize
this material [33, 48, 49, 78, 80, 81, 84, 89, 93, 105]. Chitosan produces many challenges in being
electrospun largely due to its high solution viscosity. Chitosan’s rigid D-glucosamine struc‐
tures, high crystallinity and ability to hydrogen bond lead to poor solubility in common organic
solvents [105]. The smallest diameter fibers were reported using a poly(vinyl alcohol)/chitosan
blend which resulted in nanofibers with average diameters between 20 and 100 nm [105]. Other
studies have reported nearly defect free nanofibers, with slightly larger fiber diameters using
a poly (ethylene oxide) (PEO)/chitosan blend [49, 89, 93, 105]. The successful electrospinning
of pure chitosan has only been reported using a solvent system of 90 % acetic acid and a 7 wt.
% concentration of chitosan [80].
The first successful reports of PEO/chitosan electrospun blends reported the electrospinning
of nanofibers with diameters ranging from 40 to 290 nm, but that the most consistent and defect
free fibers had an average diameter ranging from 200 to 250 nm (Spasova et al, 2004) Another
study using a PEO/chitosan blend reported defect free nanofibers with diameters that ranged
from 80 to 180 nm, but found that that the samples did not have consistent diameters. Using
Fourier transform infrared spectroscopy and differential scanning calorimeter it was discov‐
ered that the two polymers had separated and the larger fibers largely consisted of PEO and
the smaller fibers were predominately chitosan [93]. To further reduce the diameter of the
electrospun PEO/chitosan blend fibers another research group introduced Triton X-100™ as a
nonionic surfactant as well as dimethylsulphoxide as an additional solvent. These additions
greatly improved the ability to electrospin PEO/chitosan blends with a high polymer concen‐
tration and produced fibers with diameters that ranged from 40 to 110 nm [49]. The same group
also tested this nanomesh for cellular attachment and viability and found that cells more
readily attached and were able to be sustained more efficiently than on a cast film of the same
materials [49]. Another study was able to successfully electrospin PEO/chitosan blends with
no additional additives, which resulted in fibers with an average diameter of 300 nm [48]. This
group’s main objective was to test the cellular viability of a chitosan blend in the electrospun
nanomesh form. They concluded that chondrocyte cells showed good cell adhesion, prolifer‐
ation and viability on the chitosan-based electrospun material. It also concluded that the
electrospun material had a higher modulus compared to the control film made by solvent
casting. [48]
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